*********EMPIRE*********

[Mean Weimaraner]

'nother great call. CRQE EZRT catching a lil sparks too

[MONEYMADE]

,,,,,,,LOADING NUVI .012'S (OS/35M)--MONEYMADE

[TradeSmart.ai]

$TSTS IS WAKING UP TIME TO GET IN ON THE GROUND FLOOR.

[Mean Weimaraner]

I'm on this TY

[©PROPHETABLE]

EZRT WAKE UP PEEPS!!! 100M AS @.0025!!! Won't last!!!

[Penny Stocks 2.0]

RXSF $2.19 Going +$0.59, 250k FLOAT NASDAQ & MAJOR BANK FINANCING SOON.

[Den]

$ELED 0039 UP / once volume kicks in ...she'll fly

[ABCtrader1027]

$NUVI 14 MIL FLOAT... GOING ON AMAZON NEWS

[threewheeler]

I think smart TVs are way over rated, mine hooked up to computer anyways, so no need and I dont think it will sell very well with TV coming down so much every month, my computer monitor 49" Toshiba just got weeks ago for $150bucks Best Buy

[TheInvincibleBull]

$EZRT .003 up .02 destination coming

[©PROPHETABLE]

EZRT running my man! 100M AS

[ABCtrader1027]

$NUVI.............HUGE AMAZON NEWS

[RiverNorth]

GM BROTHER !!!!

[threewheeler]

CHIT 300mil x 75mil .0002s falling, looks great all MMs showing true amounts, filings out looking fantastic for next year huge MJ runner

[©PROPHETABLE]

EMbR LOOKING GREAT!!! EZRT 100M AS @ .002?!? WTF!!!

[MONEYMADE]

EMBR!!!!!!!!!! BOOOOOOOOOOOOOOOOOOM

[©PROPHETABLE]

EZRT!!!

[TheInvincibleBull]

$PTRA baby

[funnyG986]

SHOM NEWS ! MERGER/ACQUISITION IN PROGRESS. DEBT FREE COMPANY!!

[Den]

$TINO 0007 chart

http://

[MONEYMADE]

BADDEST RC PILOT ON THE PLANET:

[knrorrel]

CRCO is BKRT in ASK = BOOOOOOOMTIME COMING http://stockcharts.com/h-sc/ui?s=CRCO

[knrorrel]

GOOD MORNING

[Den]

$EFFI Tier upgraded to Pink Current

http://www.otcmarkets.com/stock/EFFI/profile

[MONEYMADE]

GOOD MORNING GENERALS!!!!!!!!!!!

[RiverNorth]

18M float. Wow

[Den]

$ELED chart >>>> very thin

http://

[$Pistol Pete$]

$PMCB This Short Video Explains Why Novo Nordisk and Sanofi Should Fear Pharmacyte Biotech

Novo Nordisk A/S (NYSE:NVO) and Sanofi SA (NYSE:SNY) may have a firm grasp on most of the diabetes market now, but a brief video explains how Pharmacyte Biotech Inc. (OTCMKTS:PMCB) could soon be a disruptor in the industry.

Investors in-tune with existing and in-development diabetes drugs will likely know that's a race Novo Nordisk A/S (NYSE:NVO) is winning, hands-down. Last year, Novo Nordisk sold $12.5 billion worth of diabetes drugs. The next nearest name, Sanofi SA (NYSE:SNY), was a distant second, with $9.5 billion worth of diabetes drug sales in 2014.

Those are big numbers, and between the two, it's tough to imagine any other players even getting a chance to carve out some sizable market share from that currently controlled by Sanofi and Novo Nordisk. Biotechnology is the great equalizer though, and it's the size of the breakthrough rather than the size of the company that can prove disruptive... even to the giants. That's why investors may want to take a look at the diabetes-treatment a small cap player called Pharmacyte Biotech Inc. (OTCMKTS:PMCB) is doing. And, for those investors keenly familiar with PMCB, they may want to watch a short video taking an even closer look at the work the company is doing on the diabetes front.

The premise is brilliant, and the underlying technology that makes it happen is incredible.

The biotechnology at the heart of PharmaCyte's solution is called Cell-in-a-Box. Pharmacyte Biotech developed Cell-in-a-Box as a way of depositing encapsulated, living, normally-functioning cells into a particular part of the body so their presence could drive a therapeutic benefit.

It's as much of a process as it is a biotech structure.

The first step in their creation is a mix of live cells (that ultimately spur or even become the therapy) and a proprietary polymer that is then dropped into another proprietary polymer. The two polymers react to form a solid object about the size of the head of the pin, with the still-living cells beneath the shell of the tiny sphere. Though only a few millimeters across, the number of living cells inside the tiny bead-sized capsule can be in the thousands.

As for how the technology could be used to treat type 1 diabetes , the encapsulated cells are insulin-producing Melligen cells. Melligen cells have been genetically engineered to produce, store and secrete insulin at levels in proportion to the levels of blood sugar in the human body. Just like a diabetic's own islet cells would recognize the presence of glucose and start producing insulin, the cells inside the PharmaCyte capsule are able to sense high levels of glucose and respond by producing an appropriate amount of insulin. A handful of these pinhead-sized capsules containing Melligen cells can replace the insulin-producing function of the pancreas from some other site in the body.

The real breakthrough, though, is the encapsulation polymer itself.

The shell of the pinhead-sized capsule keeps the cells inside, yet lets insulin out, while allowing nutrients in, and waste out. Most important though, the shell keeps the body's own immune system from killing these cells.... something most previous encapsulation approaches didn't do. All too often in the past, person's immune system would see foreign cells as a threat, attacking and eventual killing those cells.

There's still work to be done. Cell-in-a-Box as a treatment pathway for type 1 diabetes is currently in the preclinical testing phase, although it was recently determined to be safe as a means of treating type 1 diabetes by the University of Veterinary Medicine Vienna. Based on the results witnesses in the preliminary studies at the university, the company aims to move forward with plans that will ultimately result in human trials. In that the approach actually restores a body's insulin-producing capability though, the implantation of encapsulated Melligen cells truly and accurately could be described as an artificial pancreas.

As of today, investors looking for a little more insight above and beyond what they already know may want to watch a new video available at the company's website here.

The brief video offers thoughts from members of the company's International Diabetes Consortium, which now meets annually to make plans for the coming year on the matter of addressing the growing diabetes epidemic. It offers a little more insight to the underlying science, and a lot more insight as to how the science could be game-changing as well as lucrative. It may well eventually up-end much of the diabetes business Novo Nordisk and Sanofi SA are now enjoying.

[cjstocksup]

NETE ready to run ahead again IMO.

[knrorrel]

CRCO buckle up, it's time for an increase WEEEEEEEEE , GREAT SS, #7 BB now, New Website 2016, GREAT CHART -imho-
http://stockcharts.com/h-sc/ui?s=CRCO

[JohnnyBlaze]

SALES for $ACOL blowing up!

Compare:
Q2’14 to Q2’15 up 322% from $168,547 to $712,672!
Q3’14 to Q3’15 up 294% from $264,312 to $1,041,375!!!

In fact by Q2’15, ACOL has beaten FULL YEAR 2014 sales by 119%!
Q3’15 BEAT last years FULL YEAR SALES by a whopping 345%!!!

GROSS PROFIT EXPLODING!!!

Compare:
Q2’14 to Q2’15 up 328% from $112,088 to $480,058!
Q3’14 to Q3’15 up 280% from $178,734 to $679,214!!!

By the end of Q2’15, Gross Profit beat FULL YEAR 2014 G.P. by 116%!
By the end of Q3’15 ACOL BEAT FY’14 Gross Profit by 331%!!!

Then on Dec 1st, Acology Inc. puts out a shareholder newsletter stating that earlier sales projections need to be INCREASED!!! That the original 45 distribution points have erupted to over 900! And facilities are DOUBLING in square footage! Plus, they added 3 new distinguished professionals to their Advisory Board!

“New business, in the areas already described but especially in the medical industry, will continue to develop and grow exponentially as demand for the Medtainer increases” -12/01/15 Shareholder Letter

[©PROPHETABLE]

TNTY 18M Float, Reverse Merger announced today along with spin off shares!!!

[RiverNorth]

What's Good Empire?????

[yavich]

*****Scam of the decade*****

TSNP

[TradeSmart.ai]

I'M BETTING ALL ON @CRUZ WINNING THE DEBATE TIME TO MAKE THIS MONEY $$$

[TradeSmart.ai]

WELCOME BACK.

[ANTI-BAGHOLDER]

Guys, watch $CGRA

Big time news is coming! I beg everyone to read the below. We found this by doing DD, company is doing a bond offering instead of diluting! Check out the details!

$CGRA UK BOND OFFERING!!!!! ***MUST READ*** MASSIVE DD below!

http://www.cgrowthcapitalbond.com/

http://www.cgrowthcapitalbond.com/files/1714/4787/2098/CGrowth_Capital_Bond_Ltd_Issue_1_Series_1_V1.0_9th_November_2015.pdf

[Pure_Greatness]

EMBR WEBSITE!!!~~~~IS UPDATING THEIR WEBSITE!!!

Check it out
http://www.pestpilotinc.com/about.html

[threewheeler]

got CHIT going on .0002s

[RiverNorth]

EMBR: Holding For Pennies

[DTGoody]

EMBR Fireworks Coming;

[ABCtrader1027]

$NUVI 0065! 14 MIL FLOAT~ 125 MIL A/S, 35.5 MIL O/S~~ RADAR MULTI PENNIES imo,

[knrorrel]

CRCO must read WEEEEE http://investorshub.advfn.com/boards/read_msg.aspx?message_id=119175334

[BoilerRoom]

EMBR going long here Sir.....

[MONEYMADE]

,,,,,,,EMBR .003 .007 .02--MONEYMADE

[BoilerRoom]

EMBR People are getting a second chance to get in this MEGA MONSTER play. I added today!

[Pure_Greatness]

EMBR $$$$$$NO ONE'S FALLING FOR FOOLISH LIES---GO EMBR

[knrorrel]

CROC only $279 then '003 and then 0,0165 looks WEEEEEEEEEEEEEEE

[knrorrel]

now CRCO stroooooong

[knrorrel]

C R C O nooow 100% buy - watch started run to penny